Gardner Lewis Asset Management »

Day One Biopharmaceuticals I shares owned by Gardner Lewis Asset Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Gardner Lewis Asset Management from 13F filings

Historical chart of Gardner Lewis Asset Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Gardner Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Gardner Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 85k 21.44

More positions owned by Gardner Lewis Asset Management

NVIDIA Corporation (NVDA)
Amicus Therapeutics (FOLD)
Sealed Air
Air Lease Corp
Tri Pointe Homes (TPH)
Ubs Group (UBS)
Arcellx (ACLX)
Boeing Company (BA)
Blue Foundry Bancorp
Apple (AAPL)
Citigroup (C)
MasterCard Incorporated (MA)
DigitalBridge Group (DBRG)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)

View all positions for Gardner Lewis Asset Management

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I